Scribe Therapeutics to participate in upcoming investor conferences
Scribe Therapeutics (SCTX) will participate in upcoming investor conferences.
Story updates
12:07:44 PM UTC
SquawkNews
ALAMEDA, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Scribe Therapeutics Inc. (“Scribe Therapeutics”) NASDAQ:SCTX, a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and durable therapeutic inter…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.